Jayanti Mukherjee

3.3k total citations · 2 hit papers
54 papers, 2.3k citations indexed

About

Jayanti Mukherjee is a scholar working on Endocrinology, Diabetes and Metabolism, Economics and Econometrics and Analytical Chemistry. According to data from OpenAlex, Jayanti Mukherjee has authored 54 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Economics and Econometrics and 7 papers in Analytical Chemistry. Recurrent topics in Jayanti Mukherjee's work include Diabetes Treatment and Management (18 papers), Diabetes Management and Research (13 papers) and Health Systems, Economic Evaluations, Quality of Life (7 papers). Jayanti Mukherjee is often cited by papers focused on Diabetes Treatment and Management (18 papers), Diabetes Management and Research (13 papers) and Health Systems, Economic Evaluations, Quality of Life (7 papers). Jayanti Mukherjee collaborates with scholars based in United States, Canada and India. Jayanti Mukherjee's co-authors include D. Wayne Taylor, D L Sackett, Charles D. Bernholz, R. Brian Haynes, Sarah E. Holden, Sara Jenkins‐Jones, Craig J. Currie, Biswanath Bhunia, Uchenna H. Iloeje and Christopher Ll. Morgan and has published in prestigious journals such as The Science of The Total Environment, Diabetes Care and Food Chemistry.

In The Last Decade

Jayanti Mukherjee

52 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Can simple clinical measurements detect patient noncompliance?

1980 415 citations Jayanti Mukherjee et al. profile →
Bioremediation of azo dye: A review on strategies, toxicity assessment, mechanisms, bottlenecks and prospects

2024 57 citations Jayanti Mukherjee, Biswanath Bhunia et al. The Science of The Total Environment profile →

Peers

Countries citing papers authored by Jayanti Mukherjee

Since Specialization

Citations

This map shows the geographic impact of Jayanti Mukherjee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jayanti Mukherjee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jayanti Mukherjee more than expected).

Fields of papers citing papers by Jayanti Mukherjee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jayanti Mukherjee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jayanti Mukherjee. The network helps show where Jayanti Mukherjee may publish in the future.

Co-authorship network of co-authors of Jayanti Mukherjee

This figure shows the co-authorship network connecting the top 25 collaborators of Jayanti Mukherjee. A scholar is included among the top collaborators of Jayanti Mukherjee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jayanti Mukherjee. Jayanti Mukherjee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Structural and mechanistic insights into herpesvirus helicase–primase and its therapeutic inhibitors 2025 ·Nature Microbiology ·Qing Yao, Alexandre Mercier, A. Nayak, Lindsey May, Pui Yan Ho, Ariel Lewis-Ballester, (unknown), (unknown), (unknown), Jayanti Mukherjee, Christopher M. Richards, Roberto Mateo, Aesop Cho, E.B. Lansdon, Xinchao Yu	0
2	Rapid and sensitive approaches for detecting food fraud: A review on prospects and challenges 2024 ·Food Chemistry ·Ramesh Sharma, Pinku Chandra Nath, (unknown), Jayanti Mukherjee, Nibedita Mahata, (unknown), Onkar Nath Tiwari, Biswanath Bhunia	19
3	Bioremediation of azo dye: A review on strategies, toxicity assessment, mechanisms, bottlenecks and prospects breakdown → 2024 ·The Science of The Total Environment ·(unknown), Jayanti Mukherjee, (unknown), Biswanath Bhunia	57
4	Botox Treatment: A Comprehensive Review 2023 ·Asian Journal of Medicine and Health ·Jayanti Mukherjee, V. Naresh, (unknown), (unknown), T. Rama Rao	1
5	Delays in treatment intensification with oral antidiabetic drugs and risk of microvascular and macrovascular events in patients with poor glycaemic control: A n individual patient simulation study 2017 ·Diabetes Obesity and Metabolism ·(unknown), Jayanti Mukherjee, John J. Sheehan, Alexandra Ward, (unknown), Tuan Dinh, Lei Qin, Jennifer Kim	12
6	Utilization of Standard and Target-Specific Oral Anticoagulants Among Adults in the United Kingdom With Incident Atrial Fibrillation 2017 ·The American Journal of Cardiology ·Todd A. Durham, Kristen Hassmiller Lich, Anthony J. Viera, Jason P. Fine, Jayanti Mukherjee, Morris Weinberger, Stacie B. Dusetzina	9
7	Health-related quality-of-life implications of cardiovascular events in individuals with type 2 diabetes mellitus: A subanalysis from the Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus (SAVOR)-TIMI 53 trial 2017 ·Diabetes Research and Clinical Practice ·Andrew Briggs, Deepak L. Bhatt, Benjamin M. Scirica, Itamar Raz, Karissa Johnston, Shelagh M. Szabo, Klas Bergenheim, Jayanti Mukherjee, Boaz Hirshberg, Ofri Mosenzon	25
8	Association Between Weight Change, Clinical Outcomes, and Health Care Costs in Patients with Type 2 Diabetes 2016 ·Journal of Managed Care & Specialty Pharmacy ·Jayanti Mukherjee, (unknown), Nancy Smith, Kelly Bell, Marni Stott‐Miller, Donna McMorrow, Stephen S. Johnston	10
9	Evaluation of the relationship between weight change and glycemic control after initiation of antidiabetic therapy in patients with type 2 diabetes using electronic medical record data 2014 ·Diabetes Research and Clinical Practice ·Carrie McAdam‐Marx, Jayanti Mukherjee, Brandon K. Bellows, Sudhir Unni, Xiangyang Ye, Uchenna H. Iloeje, Diana Brixner	19
10	PDB72 The Impact on Utilities of Weight Loss and Weight Gain Among Canadian Patients With Type 2 Diabetes 2012 ·Value in Health ·Susan Lane, (unknown), Jennifer Sambrook, Jayanti Mukherjee, Michael Leahy, Hugh D. Tildesley	4
11	Societal preference values for advanced melanoma health states in the United Kingdom and Australia 2009 ·British Journal of Cancer ·Kathleen Beusterien, Shelagh M. Szabo, (unknown), Jayanti Mukherjee, Axel Hoos, Peter Hersey, Mark R. Middleton, Adrian R. Levy	64
12	Impact of schizophrenia and schizophrenia treatment-related adverse events on quality of life: direct utility elicitation 2008 ·Health and Quality of Life Outcomes ·Andrew Briggs, D Wild, Michael Lees, Matthew Reaney, Serdar Dursun, David Parry, Jayanti Mukherjee	90
13	Determinants of discontinuation of initial highly active antiretroviral therapy regimens in a US HIV‐infected patient cohort^* 2006 ·HIV Medicine ·Yong Yuan, G. LʼItalien, Jayanti Mukherjee, (unknown)	90
14	Changes in lipids over twelve months after initiating protease inhibitor therapy among persons treated for HIV/AIDS 2005 ·Lipids in Health and Disease ·Adrian R. Levy, Lawrence C. McCandless, P. Richard Harrigan, Robert S. Hogg, Greg Bondy, Uchenna H. Iloeje, Jayanti Mukherjee, Julio Montaner	35
15	Impact of dyslipidemia associated with Highly Active Antiretroviral Therapy (HAART) on cardiovascular risk and life expectancy*The sponsor provided the principal investigator with the results of study AI 424-008 before the study's subsequent publication but did not participate in the data analysis presented in this report. A draft of the manuscript was submitted to the sponsor before submission with the understanding that the final manuscript remained under the complete control of the principal investigator. 2005 ·The American Journal of Cardiology* ·Steven A. Grover, Louis Coupal, Norbert Gilmore, Jayanti Mukherjee	67
16	A Cost Comparison of Oral Tegafur Plus Uracil/Folinic Acid and Parenteral Fluorouracil for Colorectal Cancer in Canada 2003 ·PharmacoEconomics ·Jean A. Maroun, Carl V. Asche, (unknown), Jayanti Mukherjee, C. Cripps, Amit M. Oza, (unknown), Jacques Letarte	25
17	An examination of the effect of cytochrome P450 drug interactions of hydroxymethylglutaryl-coenzyme a reductase inhibitors on health care utilization: A Canadian population-based study 2002 ·Clinical Therapeutics ·Thomas R. Einarson, Colleen Metge, Michaël Iskedjian, Jayanti Mukherjee	32
18	Economic Evaluation of Ciprofloxacin Compared with Usual Antibacterial Care for the Treatment of Acute Exacerbations of Chronic Bronchitis in Patients Followed for 1 Year 1999 ·PharmacoEconomics ·George W. Torrance, Valery Walker, Ronald F. Grossman, Jayanti Mukherjee, David Vaughan, (unknown), Noël Lampron	36
19	Two-state mixed renewal processes for chronic disease 1999 ·Statistics in Medicine ·Richard J. Cook, (unknown), Jayanti Mukherjee, David Vaughan	19
20	A 1-Year Community-Based Health Economic Study of Ciprofloxacin vs Usual Antibiotic Treatment in Acute Exacerbations of Chronic Bronchitis 1998 ·CHEST Journal ·Ronald F. Grossman, Jayanti Mukherjee, David Vaughan, (unknown), Richard J. Cook, (unknown), Noël Lampron	115

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact